Product Information
LAMIVUDINE 150 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.4797 per EA under NDC 65862002560. Its NADAC has been published 363 times since Apr 18, 2018.
FDA first approved this application on Nov 21, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862002560
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077464FDA Approved
11/21/2016
TE Code
AB
On Market Since
11/21/2016
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 150 MG TABLET has been published 363 times since Apr 18, 2018, and over the history we have for it it has declined 61.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4797 per EA |
|---|---|
| All-time high | $1.4063 (Jul 11, 2018) |
| All-time low | $0.4413 (Apr 17, 2024) |
| Median price | $0.8913 |
| Average price | $0.8782 |
| Largest weekly change | +54.1% (May 22, 2019) |
| Weeks tracked | 363 |
| Tracking since | Apr 18, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-43.4%
5Y
-52.8%
All
-61.3%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMIVUDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.4797 per EA (NDC 65862002560), effective Aug 20, 2025.
How has the price of LAMIVUDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 61.3%. It has been tracked across 363 weekly CMS publications since Apr 18, 2018.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?
Since Apr 18, 2018, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.4413 (Apr 17, 2024) to a high of $1.4063 (Jul 11, 2018), with a median of $0.8913 per EA.
Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LAMIVUDINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LAMIVUDINE 150 MG TABLET?
LAMIVUDINE 150 MG TABLET (NDC 65862002560) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.